Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

PHARMACOLOGY > Endocrine Module > Flashcards

Endocrine Module Flashcards

1
Q

Osteoporosis

A

Systemic skeletal disorder characterized by decreased bone mass density leading to diminished stature, bone fragility, increased risk of bone fracture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

After what age in women do bone strength and density begin to decline?

A

35

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What fraction of men/women have osteoporosis?

A

1/4 women

1/8 men

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Where is the body’s calcium located?

A

99% in teeth and bones

1% in extracellular fluid and soft tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Metabolic processes calcium is involved in

A

Cell membrane function and permeability
Neuronal excitability and transmission of electrical impulses
Contraction of muscle
Conduction of electrical impulses in the heart
Blood coagulation
Platelet adhesion
Hormone secretion
Enzymatic activity
Catecholamine release from adrenal medulla
Release of chemical mediators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Bone

A

Mineralized connective tissue that provides structural support and acts as reservoir for calcium, phosphorus, magnesium, sodium, carbonate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Two main forms of calcium in bone tissue

A

Calcium phosphate
Calcium carbonate
A small amount exists in an unbound, unionized form that moves from bone to bloodstream when serum calcium is low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What % of consumed calcium is absorbed in the intestine?

A

30-50% - the rest is lost in feces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Absorption of calcium is increased by

A

Presence of vitamin D, lactose, moderate amounts of fat, high protein intake, physiologic need

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Absorption of calcium is impaired with

A

Vitamin D deficiency, high fat diet, diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How much calcium should adults consume?

A

1000 mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How much calcium should growing children, pregnant/lactating women and postmenopausal women (no HRT) consume?

A

1200 mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the best source of calcium?

A

Milk and milk products (also contain vitamin D and lactose which increase calcium absorption)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are good sources of calcium besides milk?

A

Broccoli, spinach, kale, shellfish such as clams and oysters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which 3 hormones regulate calcium and bone metabolism?

A

Parathyroid hormone
Calcitonin
Calcitriol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Parathyroid hormone

A

Secreted from parathyroid gland when serum calcium falls
Stimulates activity of osteoclasts to increase bone resorption
Increases reabsorption of calcium in tubules of kidneys
Activates calcitriol (active form of vitamin D) in the intestines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Calcitonin

A

Secreted from thyroid gland when serum calcium rises
Inhibits activity of osteoclasts to stimulate rate of deposition
Inhibits reabsorption of calcium in tubules of kidneys to increase amount excreted in urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

2 forms of vitamin D

A

Ergo-calciferol obtained from diet

Cholecalciferol - synthesized from cholesterol in skin when exposed to UV light

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Calcifediol

A

Intermediate metabolite of vitamin D (formed in liver)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Calcitriol

A

Active form of vitamin D (formed in kidneys)

Enhances intestinal absorption of calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

2 types of receptors calcitriol works on

A
  1. Membrane level - activates L-type calcium channels to modulate calcium influx across cell borders
  2. Intracellular protein - calcitriol protein complex enters nucleus and causes nuclear DNA to generate an mRNA specific for production of a calcium binding protein that intermediates in the system effects of calcitriol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Action of calcitriol at the tissue/system level

A

Stimulates intestinal calcium and phosphate transport
Increases serum calcium and phosphate from bone resorption through inducing differentiation of osteoclasts
Decreases renal excretion of calcium and phosphate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is indicative of undetected osteoporosis?

A

Shortened stature
Back pain
Spinal deformity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Causes of osteoporosis

A

Inadequate dietary calcium
Inadequate calcium absorption
Vitamin D deficiency
Disruption of calcium and bone metabolism (hypersecretion of PTH, hyposecretion of calcitonin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Which body areas are particularly vulnerable to osteoporosis related fracture?
Vertebrae of lower dorsal and lumbar spines Wrists Hips
26
When to osteoporotic fractures often occur?
After bending or lifting movements, slips, trips, falls
27
Alterable/minor risk factors
- Smoking - increases calcium excretion via kidneys - Calcium and vitamin D deficiency - increases bone resorption - Increased sodium or protein intake - increases calcium excretion via kidneys and increases bone resorption - Caffeine and alcohol - cause diuresis leading to increased calcium excretion - Lack of exercise - exercise helps retain calcium and increases bone mass density
28
Major risk factors
Female gender (esp. with advanced age, prolonged amenorrhea, menopause because estradiol limits activity of osteoclasts and progesterone stimulates osteoblasts to build new bone) Fragility fractures (less than 40 y/o) Ancestry - Asian or Caucasian Small frame - smaller bones, less mass Family history - especially maternal Glucocorticoid therapy for more than 3 months - inhibits bone deposition and increases resorption
29
Who should be assessed for presence of risk factors for osteoporosis?
All adults over 50
30
Anyone over 50 should undergo bone mass density testing if...
``` They are over 65 Fragility fractures after age 40 Family history of osteoporotic fracture Use of high dose systemic glucocorticoid therapy for 3 months Current smoking or alcohol Low body weight Rheumatoid arthritis ```
31
Anyone under 50 should undergo bone mass density testing if...
History of fragility fractures Premature menopause Primary hyperparathyroidism Hypogonadism
32
How are bone mass density tests performed?
Dual energy x-ray absorptionmetry Test scans lumbar region and one hip Takes about 10 minutes Low radiation exposure, high sensitivity for diagnosis
33
If bone mass density is normal and they are deemed low risk for fracture...
Repeated testing every 5 years
34
Recommended calcium/vitamin D intake for postmenopausal women
1200 mg calcium | 800-2000 IU vitamin D
35
If a client is deemed moderate risk for fracture...
Preventative strategies such as lifestyle change and pharmacotherapy initiated
36
In cases of severe bone mass density loss...
Pharmacological treatment for osteoporosis is required to increase bone mass density and mediate high risk of fragility fracture
37
In cases of moderate/high risk for fracture...
Bone mass density tests every 1-3 years
38
Recommended calcium/vitamin D intake for people with osteoporosis
1000 mg/day calcium 800 IU/day vitamin D Insufficient to prevent fracture, used as adjunct
39
Pharmacological treatment option
``` Hormone replacement therapy Selective estrogen receptor modulators Bisphosphonates RANKL inhibitors Parathyroid hormone ```
40
Hormone therapy
Estrogen and progesterone which have a positive effect on bone mass density - prevents loss in menopausal women and increase density in patients with existing osteoporosis
41
Who is HRT recommended in?
Women with moderate-severe symptoms due to risk of breast cancer, heart disease, stroke - hot flashes, night sweats, disrupted sleep pattern, fatigue
42
HRT should not be prescribed for
Solely for treatment of osteoporosis
43
Routes of admin for HRT
Oral and transdermal
44
Selective estrogen receptor modulators
Act as an estrogen agonist at beta-estrogen receptors in bone to inhibit osteoclast activity and reduce rate of bone resorption Act as an estrogen antagonist at alpha-estrogen receptors in breast and endometrial tissue - no risk of breast or uterine cancer
45
What are SERMs recommended for?
Prevention and treatment in asymptomatic menopausal and post-menopausal women
46
Adverse effects of SERMs
Leg cramps Hot flashes Venous thromboembolism
47
Tissue selective estrogen complexes
Combine SERMs with one or more synthetic estrogens, effective for relief of menopausal symptoms and prevention of bone loss Protect breast and endometrium from oncogenic effects of unopposed estrogen
48
What are TSECs recommended for?
Prevention of postmenopausal osteoporosis
49
Bisphosphonates
``` Drug class of choice to prevent and treat osteoporosis Inhibit osteoclast activity and reduce bone resorption, increase bone mass density and overall bone strength ```
50
How soon are results seen in bisphosphonate therapy?
1-3 months
51
How should alendronate and risedronate be administered
Orally, daily Empty stomach with full glass of water to minimize risk of esophageal irritation and improve absorption No other food or meds 30 minutes post-admin and remain upright Adverse effects related to abdominal pain and dysphagia
52
Most potent bisphosphonate
Zoledronic acid
53
How should zoledronic acid be administered and for what scenario?
IV annually for treatment of postmenopausal osteoporosis | Less frequent dosing (increased adherence) and reduced risk of GI effects
54
Atypical femur fractures are associated with
Long term use of bisphosphonates (5-7 years)
55
AFFs are often preceded by
Pain in thigh or groin weeks-months before fractuer
56
If clients report pain in thigh or groin, what tests should be performed and why?
AFF risk - radiography, bone scans, MRI
57
If any evidence of AFF is present...
Bisphosphonate therapy should be discontinued
58
Drug holidays from long term bisphosphonate therapy
Reduce AFF risk
59
Long term skeletal retention and stable bone mass density are shown after how many years of bisphosphonate therapy?
5
60
Discontinuation after 5 years of bisphosphonate therapy is appropriate for...
Those at moderate risk of fracture | In high risk, benefit of continuation of therapy outweighs risks
61
How are bisphosphonates cleared?
Renally - only 50% is deposited in bone
62
What is the drug of choice with renal dysfunction?
Denosumab
63
Receptor activator of nuclear factor kappa-B ligand inhibitors
RANKL - binds to RANK receptor on osteoclasts to promote removal of calcium from bone Estrogen deficiency stimulates upregulation of RANKL, increasing osteoclast function
64
How are RANKLs administered?
SC injection twice yearly
65
First drug of choice in postmenopausal women at high risk of fracture or in those that do not tolerate or respond to bisphosphonate therapy
RANKL inhibitors
66
Clients taking RANKL inhibitors should seek medical attention for
Signs of infection Allergic reaction Skin damage AFF
67
Common adverse effects of RANKL inhibitors
Hypocalcemia, fatigue, GI disturbance, MSK pain, skin lesions, increased risk for infection Increased risk for AFF
68
Parathyroid hormone (teriparatide)
Builds new bone
69
PTH is recommended for use in...
Cases of severe osteoporosis or those who do not respond to other treatments
70
How is PTH administered?
Daily SC for no longer than 24 months - osteosarcoma risk | Intermittent administration increases osteoblast activity and promotes deposition
71
What adverse effects are associated with PTH therapy?
Nausea, dizziness, leg cramps
72
Antiresorptive therapies include
HRT Bisphosphonates SERMs Calcitonin
73
Is combination resorptive therapy recommended?
No
74
Risk of hip fracture compared to breast cancer
1/6 fracture hip, 1/9 develop breast cancer | Death rate for hip fracture is higher
75
Long term effects of hip fracture
50% do not return to previous functional state | 20% require LTC

PHARMACOLOGY (27 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions